Key Takeaways:
Astera Labs Inc. (NASDAQ: ALAB) shares climbed 9.2% to $191.97 after RBC Capital boosted its price target on the stock by 11 percent to $250, suggesting a potential 30 percent upside for the AI infrastructure company.
The investment firm's optimism is rooted in expected strong revenue from Astera's Scorpio switches, which will be supported by sales related to Amazon's Trainium-3 AI chips beginning in the third quarter of 2026, according to an RBC note.
The upgrade comes just weeks before Astera is scheduled to report its first-quarter earnings on May 5. The company has guided for revenue between $286 million and $297 million, representing approximately 83 percent year-over-year growth at the midpoint.
The bullish analyst action reflects Astera's strategic position as a primary beneficiary of hyperscaler spending on artificial intelligence. AI research lab Anthropic recently committed to spending billions on Amazon Web Services compute power, which utilizes Astera's connectivity solutions for its in-house Trainium processors.
This solidifies Astera’s role as a key "picks-and-shovels" play in the AI boom, providing essential high-speed data connections for AI clusters. The company boasts gross margins around 75 percent, but trades at a high forward earnings multiple of about 118x.
While the growth narrative is strong, investors are weighing it against potential risks. The stock's 14-day Relative Strength Index is near 80, indicating technically overbought conditions. Furthermore, SEC filings show CEO Mohan Jitendra recently sold $57.8 million worth of stock, though the sales were part of a pre-scheduled trading plan. Investors will look to the upcoming May 5 earnings call for further justification of the stock's premium valuation.
This article is for informational purposes only and does not constitute investment advice.
